Moreover, immunoblots using protein lysates of lung fibroblasts from IPF patients showed marked upregulation of TXNDC5 and αSMA proteins, compared with that from control subjects, in response to TGFβ1 treatment (Fig. 1c). This evidence concerns the gene TXNDC5 and idiopathic pulmonary fibrosis.